NCT00241475View on ClinicalTrials.gov

Gefitinib in the Treatment of the First Relapse of Prostate Cancer Beyond Prostatectomy or Radiotherapy

PHASE2CompletedINTERVENTIONAL
Enrollment

30

Participants

Timeline

Start Date

December 31, 2003

Study Completion Date

October 31, 2005

Conditions
Prostate Cancer
Interventions
DRUG

Gefitinib

Trial Locations (1)

Unknown

Research Site, Helsinki

Sponsors

Lead Sponsor

AstraZeneca
All Listed Sponsors
lead

AstraZeneca

INDUSTRY